143 related articles for article (PubMed ID: 24093803)
1. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
[TBL] [Abstract][Full Text] [Related]
2. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.
Yan Y; Xu J; Xu B; Wen Q; Zhou J; Zhang L; Zuo L; Lv G; Shi Y
J Clin Lab Anal; 2020 Sep; 34(9):e23403. PubMed ID: 32488882
[TBL] [Abstract][Full Text] [Related]
3. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
[TBL] [Abstract][Full Text] [Related]
4. Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population.
Liu Y; Chen Z; Wei Q; Yuan F; Zhi Y; Song B; Yang J
Cancer Genet; 2012 May; 205(5):205-11. PubMed ID: 22682619
[TBL] [Abstract][Full Text] [Related]
5. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in XPC gene and risk for prostate cancer.
Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
[TBL] [Abstract][Full Text] [Related]
7. Association of XPC Gene Polymorphisms with Prostate Cancer Risk.
Kahnamouei SA; Narouie B; Sotoudeh M; Mollakouchekian MJ; Simforoosh N; Ziaee SA; Samzadeh M; Afshari M; Jamaldini SH; Imeni M; Hasanzad M
Clin Lab; 2016; 62(6):1009-15. PubMed ID: 27468562
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.
Chen Y; Zhong H; Gao JG; Tang JE; Wang R
Urol J; 2015 Jul; 12(3):2138-47. PubMed ID: 26135929
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
[TBL] [Abstract][Full Text] [Related]
10. XPC 939A>C and 499C>T polymorphisms and skin cancer risk: a meta-analysis.
Ji G; Lin Y; Cao SY; Li LZ; Chen XL; Sun BM; Chen CJ; Ma HX
Asian Pac J Cancer Prev; 2012; 13(10):4983-8. PubMed ID: 23244095
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population.
Mandal RK; Gangwar R; Kapoor R; Mittal RD
Indian J Med Res; 2012; 135(1):64-71. PubMed ID: 22382185
[TBL] [Abstract][Full Text] [Related]
12. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
[TBL] [Abstract][Full Text] [Related]
14. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
15. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk.
Zhang D; Chen C; Fu X; Gu S; Mao Y; Xie Y; Huang Y; Li Y
J Hum Genet; 2008; 53(1):18-33. PubMed ID: 18097734
[TBL] [Abstract][Full Text] [Related]
17. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
18. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
19. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
Qiu L; Wang Z; Shi X; Wang Z
Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
[TBL] [Abstract][Full Text] [Related]
20. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
Dou K; Xu Q; Han X
Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
